FATE - CIK 0001434316
The table below shows FATE THERAPEUTICS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $46.63M | $36.06M | $41.87M | $61.33M | $133.58M | $167.35M |
| Short-term investments | $157.03M | $243.01M | $273.31M | $374.89M | - | - |
| Receivables | $916.00K | $3.54M | $1.83M | $38.48M | $8.68M | $5.51M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $208.70M |
| $291.91M |
| $331.54M |
| $502.07M |
| $633.41M |
| $494.32M |
| Property, plant & equipment | $56.92M | $64.38M | $96.84M | $110.02M | $91.53M | $32.31M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $318.94M | $440.69M | $506.22M | $705.56M | $921.46M | $622.46M |
| Accounts payable | $2.66M | $9.37M | $4.72M | $8.27M | $8.61M | $6.28M |
| Total current liabilities | $36.07M | $38.52M | $39.09M | $114.05M | $81.28M | $85.56M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$1.53B | -$1.40B | -$1.21B | -$1.05B | -$769.08M | -$556.93M |
| Total equity | $207.18M | $318.73M | $368.42M | $483.94M | $678.84M | $384.44M |